{"id":"https://openalex.org/W3030280670","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9512","title":"Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC).","display_name":"Amivantamab (JNJ-61186372), an anti-EGFR-MET bispecific antibody, in patients with EGFR exon 20 insertion (exon20ins)-mutated non-small cell lung cancer (NSCLC).","alternate_titles":[],"publication_year":2020,"publication_date":"2020-05-20","ids":{"openalex":"https://openalex.org/W3030280670","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9512","mag":"3030280670"},"language":"en","primary_location":{"id":"doi:10.1200/jco.2020.38.15_suppl.9512","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9512","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.9512","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W3030280670"],"child_works_count":0,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5030107272","display_name":"Keunchil Park","orcid":"https://orcid.org/0000-0002-4846-7449","observed_orcids":["https://orcid.org/0000-0002-4846-7449"]},"institutions":[{"id":"https://openalex.org/I2802194831","display_name":"Samsung Medical Center","ror":"https://ror.org/05a15z872","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2250650973","https://openalex.org/I2802194831"]},{"id":"https://openalex.org/I848706","display_name":"Sungkyunkwan University","ror":"https://ror.org/04q78tk20","country_code":"KR","type":"education","lineage":["https://openalex.org/I848706"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Keunchil Park","raw_affiliation_strings":["Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I2802194831","https://openalex.org/I848706"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089757931","display_name":"Thomas John","orcid":"https://orcid.org/0000-0003-3399-5342","observed_orcids":["https://orcid.org/0000-0003-3399-5342"]},"institutions":[{"id":"https://openalex.org/I4210163497","display_name":"Austin Health","ror":"https://ror.org/05dbj6g52","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210163497"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Thomas John","raw_affiliation_strings":["Department of Medical Oncology, Austin Health, Heidelberg, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Austin Health, Heidelberg, Australia;","institution_ids":["https://openalex.org/I4210163497"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046400988","display_name":"Sang\u2010We Kim","orcid":"https://orcid.org/0000-0003-1065-8095","observed_orcids":["https://orcid.org/0000-0003-1065-8095"]},"institutions":[{"id":"https://openalex.org/I2801680663","display_name":"Asan Medical Center","ror":"https://ror.org/03s5q0090","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I2801680663","https://openalex.org/I4210167194"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Sang-We Kim","raw_affiliation_strings":["Asan Medical Center, Seoul, Korea, Republic of (South);"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Asan Medical Center, Seoul, Korea, Republic of (South);","institution_ids":["https://openalex.org/I2801680663"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100776199","display_name":"Jong Seok Lee","orcid":"https://orcid.org/0000-0002-7336-7124","observed_orcids":["https://orcid.org/0000-0002-7336-7124"]},"institutions":[{"id":"https://openalex.org/I2803058125","display_name":"Seoul National University Bundang Hospital","ror":"https://ror.org/00cb3km46","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388","https://openalex.org/I2803058125"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jong Seok Lee","raw_affiliation_strings":["Seoul National University Bundang Hospital, Seongnam, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Bundang Hospital, Seongnam, South Korea;","institution_ids":["https://openalex.org/I2803058125"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077503594","display_name":"Catherine A. Shu","orcid":"https://orcid.org/0000-0003-0765-7665","observed_orcids":["https://orcid.org/0000-0003-0765-7665"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Catherine A. Shu","raw_affiliation_strings":["Columbia University Medical Center, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center, New York, NY;","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100638261","display_name":"Dong\u2010Wan Kim","orcid":"https://orcid.org/0000-0001-5124-7132","observed_orcids":["https://orcid.org/0000-0001-5124-7132"]},"institutions":[{"id":"https://openalex.org/I2802835388","display_name":"Seoul National University Hospital","ror":"https://ror.org/01z4nnt86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I139264467","https://openalex.org/I2802835388"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Dong-Wan Kim","raw_affiliation_strings":["Seoul National University Hospital, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seoul National University Hospital, Seoul, South Korea;","institution_ids":["https://openalex.org/I2802835388"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5040541281","display_name":"Santiago Viteri","orcid":"https://orcid.org/0000-0002-7572-1123","observed_orcids":["https://orcid.org/0000-0002-7572-1123"]},"institutions":[{"id":"https://openalex.org/I4210096255","display_name":"Hospital Universitario Dexeus","ror":"https://ror.org/00scfzf83","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210096255"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Santiago Viteri Ramirez","raw_affiliation_strings":["Hospital Universitari Dexeus, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitari Dexeus, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210096255"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5044613951","display_name":"Alexander I. Spira","orcid":"https://orcid.org/0000-0003-1303-0447","observed_orcids":["https://orcid.org/0000-0003-1303-0447"]},"institutions":[{"id":"https://openalex.org/I4210122908","display_name":"Virginia Cancer Specialists","ror":"https://ror.org/03tbabt10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210122908"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Alexander I. Spira","raw_affiliation_strings":["Virginia Cancer Specialists, Fairfax, VA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Virginia Cancer Specialists, Fairfax, VA;","institution_ids":["https://openalex.org/I4210122908"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024203424","display_name":"Joshua K. Sabari","orcid":"https://orcid.org/0000-0002-1556-1543","observed_orcids":["https://orcid.org/0000-0002-1556-1543"]},"institutions":[{"id":"https://openalex.org/I57206974","display_name":"New York University","ror":"https://ror.org/0190ak572","country_code":"US","type":"education","lineage":["https://openalex.org/I57206974"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Joshua K. Sabari","raw_affiliation_strings":["New York University School of Medicine, New York, NY;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"New York University School of Medicine, New York, NY;","institution_ids":["https://openalex.org/I57206974"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023055777","display_name":"Ji\u2010Youn Han","orcid":"https://orcid.org/0000-0001-5033-0006","observed_orcids":["https://orcid.org/0000-0001-5033-0006"]},"institutions":[{"id":"https://openalex.org/I4210120052","display_name":"National Cancer Center","ror":"https://ror.org/02tsanh21","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4210120052"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ji-Youn Han","raw_affiliation_strings":["National Cancer Center, Gyeonggi-Do, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Center, Gyeonggi-Do, South Korea;","institution_ids":["https://openalex.org/I4210120052"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5062111870","display_name":"Jos\u00e9 Manuel Trigo","orcid":"https://orcid.org/0000-0002-4489-2683","observed_orcids":["https://orcid.org/0000-0002-4489-2683"]},"institutions":[{"id":"https://openalex.org/I4210157481","display_name":"Hospital Cl\u00ednico Universitario Virgen de la Victoria","ror":"https://ror.org/05xxs2z38","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I158283456","https://openalex.org/I4210157481"]}],"countries":["ES"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Jose Manuel Trigo","raw_affiliation_strings":["Hospital Universitario Virgen de la Victoria, M\u00e1laga, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Universitario Virgen de la Victoria, M\u00e1laga, Spain;","institution_ids":["https://openalex.org/I4210157481"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071066396","display_name":"Chee Khoon Lee","orcid":"https://orcid.org/0000-0003-2955-9820","observed_orcids":["https://orcid.org/0000-0003-2955-9820"]},"institutions":[{"id":"https://openalex.org/I4210123059","display_name":"St George Hospital","ror":"https://ror.org/02pk13h45","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210123059"]}],"countries":["AU"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Chee Khoon Lee","raw_affiliation_strings":["St George Hospital, Kogarah, Australia;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"St George Hospital, Kogarah, Australia;","institution_ids":["https://openalex.org/I4210123059"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005962138","display_name":"Ki Hyeong Lee","orcid":"https://orcid.org/0000-0002-7830-5950","observed_orcids":["https://orcid.org/0000-0002-7830-5950"]},"institutions":[{"id":"https://openalex.org/I163753206","display_name":"Chungbuk National University","ror":"https://ror.org/02wnxgj78","country_code":"KR","type":"education","lineage":["https://openalex.org/I163753206"]},{"id":"https://openalex.org/I4210161026","display_name":"Chungbuk National University Hospital","ror":"https://ror.org/05529q263","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I163753206","https://openalex.org/I4210161026"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ki Hyeong Lee","raw_affiliation_strings":["Chungbuk National University Hospital, Cheongju, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Chungbuk National University Hospital, Cheongju, South Korea;","institution_ids":["https://openalex.org/I163753206","https://openalex.org/I4210161026"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090329560","display_name":"Nicolas Girard","orcid":"https://orcid.org/0000-0001-9909-2299","observed_orcids":["https://orcid.org/0000-0001-9909-2299"]},"institutions":[{"id":"https://openalex.org/I80043","display_name":"Institut Curie","ror":"https://ror.org/04t0gwh46","country_code":"FR","type":"nonprofit","lineage":["https://openalex.org/I80043"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Nicolas Girard","raw_affiliation_strings":["Institut Curie, Paris, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Institut Curie, Paris, France;","institution_ids":["https://openalex.org/I80043"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067727178","display_name":"Patricia A. Lorenzini","orcid":"https://orcid.org/0009-0000-7580-2209","observed_orcids":["https://orcid.org/0009-0000-7580-2209"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Patricia A Lorenzini","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101998977","display_name":"John Xie","orcid":"https://orcid.org/0000-0001-7016-6696","observed_orcids":["https://orcid.org/0000-0001-7016-6696"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"John Xie","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027461408","display_name":"Amy Roshak","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Amy Roshak","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034407359","display_name":"Meena Thayu","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Meena Thayu","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042316451","display_name":"Roland Elmar Knoblauch","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Roland Elmar Knoblauch","raw_affiliation_strings":["Janssen Research & Development, LLC, Spring House, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Janssen Research & Development, LLC, Spring House, PA;","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064697305","display_name":"Byoung Chul Cho","orcid":"https://orcid.org/0000-0002-5562-270X","observed_orcids":["https://orcid.org/0000-0002-5562-270X"]},"institutions":[{"id":"https://openalex.org/I193775966","display_name":"Yonsei University","ror":"https://ror.org/01wjejq96","country_code":"KR","type":"education","lineage":["https://openalex.org/I193775966"]},{"id":"https://openalex.org/I4210160791","display_name":"Yonsei University Health System","ror":"https://ror.org/04sze3c15","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I4210160791"]},{"id":"https://openalex.org/I4405258038","display_name":"Yonsei Cancer Hospital","ror":"https://ror.org/0005vby86","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I193775966","https://openalex.org/I2799970807","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Byoung Chul Cho","raw_affiliation_strings":["Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Yonsei Cancer Center, Yonsei University College of Medicine, Seoul, South Korea;","institution_ids":["https://openalex.org/I193775966","https://openalex.org/I4210160791","https://openalex.org/I4405258038"]}]},{"author_position":"last","author":{"id":null,"display_name":"on behalf of the CHRYSALIS Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"on behalf of the CHRYSALIS Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":5,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":70,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"38","issue":"15_suppl","first_page":"9512","last_page":"9512"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10755","display_name":"HER2/EGFR in Cancer Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/amivantamab","display_name":"amivantamab","score":0.9980000257492065},{"id":"https://openalex.org/keywords/egfr-exon-20-insertion-mutation","display_name":"EGFR exon 20 insertion","score":0.8700000047683716},{"id":"https://openalex.org/keywords/non-small-cell-lung-cancer","display_name":"non-small cell lung cancer","score":0.9660000205039978},{"id":"https://openalex.org/keywords/bispecific-antibodies","display_name":"bispecific antibodies","score":0.8790000081062317},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.4620000123977661},{"id":"https://openalex.org/keywords/recommended-phase-ii-dose","display_name":"recommended phase 2 dose","score":0.7789999842643738},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.6660000085830688},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6809999942779541},{"id":"https://openalex.org/keywords/skin-rash","display_name":"rash","score":0.45399999618530273},{"id":"https://openalex.org/keywords/egfr-tyrosine-kinase-inhibitors","display_name":"EGFR tyrosine kinase inhibitors","score":0.6880000233650208},{"id":"https://openalex.org/keywords/met-amplification","display_name":"MET amplification","score":0.5630000233650208}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.943528413772583},{"id":"https://openalex.org/C2778570526","wikidata":"https://www.wikidata.org/wiki/Q653197","display_name":"Rash","level":2,"score":0.6850760579109192},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6834163665771484},{"id":"https://openalex.org/C2777930144","wikidata":"https://www.wikidata.org/wiki/Q25100112","display_name":"T790M","level":5,"score":0.6647226810455322},{"id":"https://openalex.org/C2779177807","wikidata":"https://www.wikidata.org/wiki/Q3658562","display_name":"non-small cell lung cancer (NSCLC)","level":4,"score":0.5969793200492859},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.5615571737289429},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5324243903160095},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5007355213165283},{"id":"https://openalex.org/C2778822529","wikidata":"https://www.wikidata.org/wiki/Q1951525","display_name":"Progressive disease","level":3,"score":0.4734373092651367},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.45967820286750793},{"id":"https://openalex.org/C2777063308","wikidata":"https://www.wikidata.org/wiki/Q1435822","display_name":"Neutropenia","level":3,"score":0.4544345736503601},{"id":"https://openalex.org/C2779984678","wikidata":"https://www.wikidata.org/wiki/Q2145898","display_name":"Response Evaluation Criteria in Solid Tumors","level":4,"score":0.43537256121635437},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.41469770669937134},{"id":"https://openalex.org/C2780580887","wikidata":"https://www.wikidata.org/wiki/Q417824","display_name":"Gefitinib","level":4,"score":0.41413992643356323},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.348784863948822},{"id":"https://openalex.org/C2779438470","wikidata":"https://www.wikidata.org/wiki/Q424401","display_name":"Epidermal growth factor receptor","level":3,"score":0.32661116123199463},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C81729549","wikidata":"https://www.wikidata.org/wiki/Q4649475","display_name":"A549 cell","level":3,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1200/jco.2020.38.15_suppl.9512","doi":"https://doi.org/10.1200/jco.2020.38.15_suppl.9512","is_oa":false,"landing_page_url":"https://doi.org/10.1200/jco.2020.38.15_suppl.9512","pdf_url":null,"source":{"id":"https://openalex.org/S15137598","display_name":"Journal of Clinical Oncology","issn_l":"0732-183X","issn":["0732-183X","1527-7755"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Clinical Oncology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":0.98580002784729,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320337415","display_name":"Janssen Research and Development","ror":"https://ror.org/03qd7mz70"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W6998550496","https://openalex.org/W4327944896","https://openalex.org/W3138438276","https://openalex.org/W3191219220","https://openalex.org/W3024670790","https://openalex.org/W4304632324","https://openalex.org/W3138952535","https://openalex.org/W7162859771","https://openalex.org/W3193522287","https://openalex.org/W4388045874"],"abstract_inverted_index":{"9512":[0],"Background:":[1],"EGFR":[2,9,51,56],"exon20ins-mutated":[3],"NSCLC":[4,71,97],"is":[5,15,22],"generally":[6],"refractory":[7],"to":[8,175],"tyrosine":[10],"kinase":[11],"inhibitors":[12],"(TKIs)":[13],"and":[14,38,41,60,98,107,165,200,232,243,262,294,322,363,379],"associated":[16],"with":[17,49,69,95,105,116,152,274,342,385,388],"poor":[18],"prognosis.":[19],"Amivantamab":[20,376],"(JNJ-61186372)":[21],"a":[23,89,99,275,389],"novel,":[24],"fully":[25],"human":[26],"anti-EGFR-MET":[27],"bispecific":[28],"antibody":[29],"whose":[30],"mechanism":[31],"of":[32,67,82,127,146,253,278,336],"action":[33],"can":[34],"target":[35],"both":[36],"EGFR-":[37,106],"MET-driven":[39],"disease":[40,53,118,168,314],"has":[42],"shown":[43],"monotherapy":[44],"activity":[45,382],"in":[46,93,103,251,345,383],"patients":[47],"(pts)":[48],"diverse":[50],"mutant":[52],"characterized":[54],"by":[55,139],"C797S,":[57],"T790M,":[58],"exon20ins,":[59],"MET":[61],"amplification.":[62],"We":[63],"present":[64],"preliminary":[65],"results":[66],"pts":[68,94,104,115,132,151,162,192,210,302,321,325,347,362,370,384],"advanced":[70,96],"harboring":[72,211],"exon20ins":[73,117,153,212,386],"mutations":[74,154,213],"from":[75],"CHRYSALIS,":[76],"an":[77],"ongoing":[78,343],"phase":[79,92,102,123],"1":[80,205],"study":[81,87],"amivantamab":[83,157],"(NCT02609776).":[84],"Methods:":[85],"This":[86,110],"comprises":[88],"dose":[90,100,125],"escalation":[91],"expansion":[101],"MET-mutated":[108],"disease.":[109],"analysis":[111],"includes":[112],"all":[113,331],"enrolled":[114],"who":[119,303,326,371],"received":[120,156],"the":[121,159,176,208,216,218,270,282,300],"recommended":[122],"2":[124],"(RP2D)":[126],"1050":[128],"mg":[129],"(1400":[130],"mg,":[131],"\u226580":[133],"kg)":[134],"amivantamab.":[135],"Response":[136],"was":[137,193,204,267,289,317,338,354],"assessed":[138],"investigator":[140],"per":[141],"RECIST":[142],"v1.1.":[143],"Results:":[144],"As":[145],"30":[147],"Oct":[148],"2019,":[149],"50":[150,209],"had":[155,166,171,183,304,327,372],"at":[158,215,348],"RP2D.":[160],"39/50":[161],"were":[163,198,225,249,256],"response-evaluable":[164,191,272,320,361],"\u22652":[167],"assessments":[169],"or":[170,312],"discontinued":[172],"therapy":[173],"prior":[174,184,202,305,328,373],"assessment":[177],"period;":[178],"among":[179],"these":[180],"pts,":[181,273],"29":[182,301],"platinum-based":[185],"chemotherapy":[186],"(PBCT).":[187],"Median":[188,351],"age":[189],"for":[190,299,319,324,360,369],"61":[194],"y":[195],"(40\u201378),":[196],"51%":[197],"female,":[199],"median":[201,276,334],"lines":[203],"(0\u20137).":[206],"In":[207],"treated":[214],"RP2D,":[217],"most":[219],"common":[220],"adverse":[221],"events":[222],"(AEs)":[223],"reported":[224,250],"rash":[226,266],"(72%),":[227],"infusion":[228],"related":[229],"reaction":[230],"(60%),":[231],"paronychia":[233],"(34%).":[234],"Additional":[235],"EGFR-related":[236],"AEs":[237,248],"included":[238],"stomatitis":[239],"(16%),":[240],"pruritus":[241],"(14%),":[242],"diarrhea":[244,261],"(6%).":[245],"Grade":[246],"\u22653":[247,265],"36%":[252,290],"pts;":[254],"6%":[255],"treatment-related.":[257],"One":[258],"grade":[259,264],"3":[260],"no":[263],"reported.":[268],"Among":[269,330],"39":[271],"follow-up":[277],"4":[279],"months":[280,340,356,365],"(1\u201326),":[281],"overall":[283],"response":[284,287,337],"rate":[285,310],"(\u2265partial":[286],"[PR])":[288],"(95%":[291,296,357,366],"CI,":[292,297,358,367],"21\u201353),":[293],"41%":[295],"24\u201361)":[298],"PBCT.":[306,329,374],"The":[307],"clinical":[308],"benefit":[309],"(\u2265PR":[311],"stable":[313],"\u226511":[315],"weeks)":[316],"67%":[318],"72%":[323],"14":[332],"responders,":[333],"duration":[335],"10":[339],"(1\u201316),":[341],"responses":[344],"9":[346],"data":[349],"cutoff.":[350],"progression-free":[352],"survival":[353],"8.3":[355],"3.0\u201314.8)":[359],"8.6":[364],"3.7\u201314.8)":[368],"Conclusions:":[375],"demonstrates":[377],"robust":[378],"durable":[380],"antitumor":[381],"disease,":[387],"manageable":[390],"safety":[391],"profile.":[392],"Clinical":[393],"trial":[394],"information:":[395],"NCT02609776":[396],".":[397]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W3030280670","counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":12},{"year":2021,"cited_by_count":41},{"year":2020,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2020-06-05T00:00:00"}
